Vnitr Lek 1996, 42(9):602-604

[The effect of gender on prevalence and survival in thyroid carcinoma].

J Němec, P Chytrý, J Dvorák, P Vlcek, M Neradilová, P Racek, T Blazek, V Zeman
Klinika nukleární medicíny 2. LF UK, Praha Motol.

Based on their own experience with a large group of patients with thyroid cancers, the authors confirm the higher prevalence of differentiated thyroid cancers both papillary and follicular (1 : 3,5) in females, while the differences in anaplastic and medullary cancers are much less prominent. Survival of females in univariate studies is much higher in both papillary and follicular cancers compared to males, in multivariate studies these differences lose their significance and only in papillary cancers under the age of 40 years at diagnosis and in a subgroup of papillofollicular cancers the differences retain their significance. The authors therefore deduce that differences found in univariate studies are significantly influenced by other factors such as age at the diagnosis and the spread of disease at the diagnosis.

Keywords: Adenocarcinoma, Follicular /epidemiology/; Adult; Carcinoma /epidemiology/; Carcinoma, Medullary /epidemiology/; Carcinoma, Papillary /epidemiology/; Czech Republic /epidemiology/; Female; Humans; Male; Prevalence; Sex Factors; Survival Rate; Thyroid Neoplasms /epidemiology/

Published: September 1, 1996  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němec J, Chytrý P, Dvorák J, Vlcek P, Neradilová M, Racek P, et al.. [The effect of gender on prevalence and survival in thyroid carcinoma]. Vnitr Lek. 1996;42(9):602-604.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.